Q&A: Human Challenge Studies of COVID-19 Underway in UK
Q&A: Human Challenge Studies of COVID-19 Underway in UK
Researchers at Imperial College London and the University of Oxford are exposing healthy volunteers to SARS-CoV-2 for science.
Q&A: Human Challenge Studies of COVID-19 Underway in UK
Q&A: Human Challenge Studies of COVID-19 Underway in UK

Researchers at Imperial College London and the University of Oxford are exposing healthy volunteers to SARS-CoV-2 for science.

Researchers at Imperial College London and the University of Oxford are exposing healthy volunteers to SARS-CoV-2 for science.

virus
Biosurveillance for Viral Infections
Biosurveillance for Viral Infections
The Creative Services Team in Collaboration with Tecan | Jun 8, 2021
Scientists use ELISAs to assess the immunity and etiology of immune responses to coronavirus during the COVID-19 pandemic.
BioHub Network Aims to Advance Sharing of Pathogens for Research
BioHub Network Aims to Advance Sharing of Pathogens for Research
Shawna Williams | Jun 6, 2021
The World Health Organization–led program will promote equity in addition to facilitating access to samples, a WHO official involved in the project tells The Scientist.
Farmed Atlantic Salmon Likely Passed Virus to Wild Pacific Salmon
Farmed Atlantic Salmon Likely Passed Virus to Wild Pacific Salmon
Abby Olena | May 27, 2021
New genomic analyses reveal that piscine orthoreovirus first came to the Pacific in 1989, around the same time that salmon farms in the area started importing Atlantic salmon eggs from Europe.
COVID-19’s Origins Need Further Investigation, Say Scientists
COVID-19’s Origins Need Further Investigation, Say Scientists
Catherine Offord | May 14, 2021
A letter signed by 18 researchers argues that hypotheses about zoonotic spillover or accidental lab release both “remain viable” in the absence of additional evidence.
T Cell–Boosting Zika Vaccine Protects Mice from the Virus
T Cell–Boosting Zika Vaccine Protects Mice from the Virus
Ruth Williams | May 12, 2021
By avoiding the production of antibodies, something vaccines ordinarily induce, the immunization sidesteps the problem of antibody-dependent enhancement, which can amplify infection by a similar virus and is known to occur with dengue and Zika.
Approaches to Processing SARS-CoV-2 Samples for RNA Detection
Approaches to Processing SARS-CoV-2 Samples for RNA Detection
The Scientist Creative Services Team in collaboration with MilliporeSigma | May 10, 2021
Discover new RNA extraction and purification strategies and how they enable reliable and sensitive viral detection.
What Scientists Know About the B.1.617 Coronavirus Variant
What Scientists Know About the B.1.617 Coronavirus Variant
Shawna Williams | May 3, 2021
While some experts speculate the variant could be partially responsible for India’s current surge in SARS-CoV-2 infections, information about the effects of its mutations is only beginning to emerge.
Sewage Sampling Robots Speed SARS-CoV-2 Detection
Sewage Sampling Robots Speed SARS-CoV-2 Detection
Ruth Williams | May 1, 2021
An automated wastewater monitoring technique could enable researchers to predict outbreaks of the virus up to a week in advance.
Infographic: How to Ferret Out SARS-CoV-2 in Sewage
Infographic: How to Ferret Out SARS-CoV-2 in Sewage
Ruth Williams | May 1, 2021
Researchers use magnetic nanoparticles and liquid-handling robots in an effort to detect COVID-19 outbreaks early.
Some Viruses Use an Alternative Genetic Alphabet
Some Viruses Use an Alternative Genetic Alphabet
Abby Olena | Apr 29, 2021
In a trio of studies, researchers follow up on a 40-year-old finding that certain bacteriophages replace adenine with so-called diaminopurine, perhaps to avoid host degradation.
LabTalk Podcast - A Modern Trojan Horse: Delivering Combination Immunotherapies to Solid Tumors 
LabTalk Podcast - A Modern Trojan Horse: Delivering Combination Immunotherapies to Solid Tumors 
The Scientist Creative Services Team in Collaboration with IsoPlexis | Apr 26, 2021
Katie McKenna discusses a combination CAR T and viral therapy that kills solid tumors.
Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans
Q&A: New Tool Ranks Viruses by Their Risk of Jumping to Humans
Jef Akst | Apr 9, 2021
Researchers involved in a long-term project to identify viruses of concern have now assessed the risk factors that could help forecast which pathogens are the most likely to spillover from wildlife to people.
Boosting CAR T Cell Therapy for Solid Tumors
Boosting CAR T Cell Therapy for Solid Tumors
The Scientist Creative Services Team in Collaboration with IsoPlexis | Apr 5, 2021
Katie McKenna will discuss how oncolytic viral therapy enhances CAR-T cell killing of cancer cells.
LabTalk Podcast - Predicting the Immune Response with Single-Cell Analysis: Autoimmunity, Vaccination, and COVID-19
LabTalk Podcast - Predicting the Immune Response with Single-Cell Analysis: Autoimmunity, Vaccination, and COVID-19
The Scientist Staff | Mar 31, 2021
Researchers identify signatures that predict how a person will respond to an immune system stimulus.
Securing the Antibody Supply Chain through Recombinant Antibody Technology: A COVID-19 Case Study
Securing the Antibody Supply Chain through Recombinant Antibody Technology: A COVID-19 Case Study
The Scientist Creative Services Team in collaboration with Sartorius Corporation | Mar 29, 2021
Nicholas Hutchings will discuss how recombinant antibody technology can speed up the response to a pandemic.
Q&A: Data Gaps Hinder Monitoring of SARS-COV-2 Variants
Q&A: Data Gaps Hinder Monitoring of SARS-COV-2 Variants
Jef Akst | Mar 24, 2021
Martha Nelson of the National Institute of Allergy and Infectious Diseases talks about the need to balance data sharing and patient privacy concerns when tracking the spread of variants.
UPDATED
Ebola Outbreak in Guinea Originated from Past Epidemic
Ebola Outbreak in Guinea Originated from Past Epidemic
Asher Jones | Mar 15, 2021
Genetic analyses suggest that the virus came from a patient who survived the 2013–2016 West African outbreak.
Oxford/AstraZeneca COVID-19 Vaccine on Hold in Some Countries
Oxford/AstraZeneca COVID-19 Vaccine on Hold in Some Countries
Asher Jones | Mar 12, 2021
Rollouts of the shot have ground to a halt following reports of blood clots, but health authorities say that these fears are unfounded and vaccination programs should continue.
COVID-19 Vaccine Combos Aim to Boost Immunity
COVID-19 Vaccine Combos Aim to Boost Immunity
Asher Jones | Mar 9, 2021
Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.